Table 2.
T-cell populations† | CD4+ cell subpopulations (%) | ||||
Time course | |||||
Patient* | (months after admission) | CD4+ | CD8+ | CD45RA-/CD45RO+ | CD45RA+/CD45RO- |
1 | Admission | 308 | 91 | 68 | 15 |
Polychondritis/female/ | 5 | 4 | 2 | 98 | 0 |
41 years/1985 | 7 | 300 | 11 | 70 | 15 |
12 | 392 | 470 | 40 | 50 | |
2 | Admission | 130 | 17 | 40 | 50 |
SLE/female/27 years/ | 5 | 71 | 551 | 95 | 3 |
1987 | 7 | 149 | 427 | 93 | 4 |
10 | 227 | 239 | 60 | 20 | |
3 | Admission | 30 | 42 | 68 | 18 |
SLE/female/48 years/ | 3 | 30 | 129 | 99 | 0 |
1993 | 4 | 86 | 346 | 89 | 7 |
6 | 265 | 179 | 62 | 25 | |
4 | Admission | 73 | 98 | 52 | 27 |
SLE/male/37 years/ | 2 | 76 | 600 | 95 | 0 |
1989 | 3 | 19 | 118 | 88 | 0 |
*Characteristics: disease/sex/age/year of diagnosis. †T-cell populations determined by flow cytometry; number of cells/μ l blood.